CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma

American Journal of Pathology

Volumn 148, Issue 5, 1996, Pages 1387-1396

  Pammer, Johannes ^b   Plettenberg, Andreas ^a   Weninger, Wolfgang ^a   Diller, Barbara ^a   Mildner, Michael ^a   Uthman, Aumaid ^a   Issing, Wolfgang ^c   Stürzl, Michael ^d   Tschachler, Erwin ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Universitatsklinik fur Dermatologie   (Austria)

^c UNIVERSITY OF MUNICH   (Germany)

^d MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; NERVE GROWTH FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; GRANULATION TISSUE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KAPOSI SARCOMA; PRIORITY JOURNAL; SPINDLE CELL; VASCULAR ENDOTHELIUM;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIGENS, CD31; ANTIGENS, CD34; ANTIGENS, CD40; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BLOTTING, WESTERN; CELL ADHESION MOLECULES; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; SARCOMA, KAPOSI; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0029883722     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Banchereau J, Bazan F, Blanchard D, Briere F Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S The CD40 antigen and its ligand. Annu Rev Immunol 1994, 12 881-922
2. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death Cell 1994, 76:959-962
3. Crowe PD, VanArsdale TL Walter BN Ware CF, Hession CH Ehrenfels B, Browning JL, Din WS, Goodwin RG, Smith CA: A lymphotoxin-β-specific receptor. Science 1994, 264:707-710
4. Stamenkovic I, Clark EA, Seed B: A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 1989, 8:1403-1410
5. Paulie S, Ehlin-Henriksson B, Mellstedt H, Koho H, Ben-Aissa H, Perlman B: A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes Cancer Immunol Immunother 1985, 20: 23-28
6. Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I, Banchereau J. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 1994, 180:1263-1272
7. Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spnggs MK: CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993, 178:669-674
8. Galy AHM, Spitz H: CD40 is functionally expressed on human thymic epithelial cells. J Immunol 1992, 149: 775-782
9. Zong YS, Lin H, Choy DT, Sham JS, Wei W, Chan KH, Ng MH: Nasopharyngeal carcinoma and lymphoinfiltration. Oncology 1991, 48:290-296
10. Young LS, Dawson CW, Brown KW, Rickinson AB. Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes. Int J Cancer 1989, 43:786-794
11. Kanitakis J, Zambruno G, Roche P, Vaschieri C, Valle A, Thivolet J, Banchereau J: CD40 antigen expression in normal and diseased human skin. J Invest Dermatol 1991, 96.646A
12. Möller P, Mielke B: Extensive analysis of tissue distribution of antigens defined by new clustered and unclustered B-cell antibodies. Leukocyte Typing. IV White Cell Differentiation Antigens. Edited by W Knapp, B Dörken, WR Gilks, EP Rieber, RE Schmidt, H Stein, AEGK von dem Borne Oxford, Oxford University Press, 1989, pp 175-177
13. Karmann K, Hughes CCW, Schechner J, Fanslow WC, Pober JS. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 1995, 92 4342-4346
14. Hollenbaugh D, Mischel-Petty N, Edwards CP, Simon JC, Denfeld RW, Kiener PA, Aruffo A: Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995, 182.33-40
15. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kleff E: The Epstein-Barr virus transforming protein LMP-1 engages signalling proteins for the tumor necrosis factor receptor family Cell 1995, 80.389-399
16. Rappersberger K, Wolff K, Stingl G: Kaposi's sarcoma Dermatology in General Medicine. Edited by TB Fitzpatrick, AZ Eisen, K Wolff, IM Freedberg, KF Austen. New York, McGraw Hill, 1993, pp 1244-1256
17. Stürzl M, Brandstetter H, Roth WK: Kaposi's sarcoma: a review of gene expression and ultrastructure of KS spindle cells in vivo. Aids Res Hum Retroviruses 1992, 8.1753-1763
18. Roth WK, Brandstetter H, Stürzl M Cellular and molecular features of HIV-associated Kaposi's sarcoma AIDS 1992, 6 895-913
19. Nickoloff BJ PECAM-1 (CD31) is expressed on proliferating endothelial cells, stromal spindle shaped cells, and dermal dendrocytes in Kaposi's sarcoma Arch Dermatol 1993, 129:249-250
20. Nickoloff BJ: The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin fixed normal skin, and on proliferating endothelial cells and stromal spindle shaped cells in Kaposi's sarcoma. Arch Dermatol 1991, 127:523-529
21. Azzarelli A, Mazzaferro V, Quagliuolo V, Audisio RA, Colella G, Bandieramonte G, Dossena G, Gennari L: Kaposi's sarcoma, malignant tumor or proliferative disorder Eur J Cancer Ciln Oncol 1988, 24: 973-978
22. Ensoli B, Barillari G, Gallo RC. Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma. Immunol Rev 1992, 127:147-155
23. Fiorelli V, Gendelman R, Samaniego F, Markham PD, Ensoli B: Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J Clin Invest 1995, 95:1723-1734
24. Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, Raffeld M, Cafaro A, Chang HK, Brady JN, Gallo RC: Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma Nature 1994, 371:674-680
25. Peterman TA, Jaffe HW, Beral V: Epidemiologic clues to the etiology of Kaposi's sarcoma AIDS 1993, 7 605-611
26. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869
27. Moore PS, Chang Y: Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection N Engl J Med 1995, 332: 1181-1185
28. Huang YQ, Li JJ, Kaplan MH, Poiesz B, Katabira E, Zhang WC, Feiner D, Friedman-Kien AE: Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma Lancet 1995, 345 759-761
29. Plettenberg A, Ballaun C, Pammer J, Mildner M, Strunk D, Weninger W, Tschachler E: Human melanocytes and melanoma cells constitutively express the bcl-2 proto-oncogene in situ and in cell culture. Am J Pathol 1995, 146:651-659
30. Roth WK, Werner S, Risau W, Remberger K, Hofschneider PH: Cultured, AIDS-related Kaposi's sarcoma cells express endothelial markers and are weakly malignant in vitro Int J Cancer 1988, 42.767-773
31. Roth WK, Werner S, Schirren CG, Hofschneider PH: Depletion of PDGF from serum inhibits growth of AIDS-related and sporadic Kaposi's sarcoma cells in culture. Oncogene 1989, 4 483-487
32. Braesch-Andersen S, Paulie S, Koho H, Nika H, Aspenström P, Perlman P Biochemical characteristics and partial amino acid sequence of the receptor-like human B-cell and carcinoma antigen CDw40. J Immunol 1989, 142:562-567
33. Nickoloff BJ, Griffiths CE. Factor XIIIa-expressing dermal dendrocytes in AIDS-associated cutaneous Kaposi's sarcomas. Science 1989, 241:1736-1737
34. Nestle FO, Zheng XG, Thompson CB, Turka LA, Nickoloff BJ: Characterization of dermal dendritic cells obtained from normal human skin reveals pnenotypic and functionally distinctive subsets. J Immunol 1993, 151: 6535-6545
35. Wrone-Smith T, Johnson T, Nelson B, Boise LH, Thompson CB, Nunez G, Nickoloff BJ: Discordant expression of bcl-x and bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo. Am J Pathol 1995, 146. 1079-1088
36. Valle A, Zuber CE, Defrance T, Djossou O, De Rie M, Banchereau J. Activation of human B lymphocytes through CD40 and interleukin 4 Eur J Immunol 1989, 19.1463-1467
37. Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E Epstein-Barr virus latent membrane protein (LMP 1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA 2 and LMP 1 cooperatively induce CD23 J Virol 1990, 64:2309-2318
38. Giraldo G, Beth E, Kourilsky FM, Henle W, Mike V, Huraux JM, Anderson HK, Gharbi MR, Kyalwazi SK, Puissant A: Antibody patterns to herpesviruses in Kaposi's sarcoma: serological association of European Kaposi's sarcoma with cytomegalovirus Int J Cancer 1975, 15:839-848
39. Grody WW, Lewin KJ, Naeim F. Detection of cytomegalovirus DNA in classic and epidemic Kaposi's sarcoma by in situ hybridization. Hum Pathol 1988, 19: 524-528
40. Giraldo G, Beth E, Haguenau F: Herpes-type virus particles in tissue culture of Kaposi's sarcoma from different geographic regions J Natl Cancer Inst 1972, 49:1509-1526
41. Boldogh I, Beth E, Huang ES, Kyalwazi SK, Giraldo G. Kaposi's sarcoma IV. Detection of CMV DNA, CMV RNA and CMNA in tumor biopsies. Int J Cancer 1981, 28.469-474
42. Broshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, McGee J, Weiss RA, O'Leary JJ: Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells Nature Medicine 1995, 1 1274-1278.
43. Lebbe C, de Cremoux P, Rybojad M, Costa da Cunha C, Morel P, Calvo F: Kaposi's sarcoma and new herpesvirus Lancet 1995, 345.1180
44. Liu YJ, Mason DY, Johnson GD, Abbot S, Gregory CD, Hardie DL, Gordon J, MacLennan IC. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol 1991, 21 1905-1910
45. Armitage RJ, Fanslow WC, Strockbine L, Sato TA, Clifford KN, Macduff BM, Anderson DM, Gimpel SD, Davis-Smith T, Maliszewski CR, Clark EA, Smith CA, Grabstein KH, Cosman D, Spriggs MK Molecular and biological characterization of a murine ligand for CD40. Nature 1992, 357 80-82
46. Chor PJ, Santa Cruz DJ Kaposi's sarcoma: a clinicopathologic review and differential diagnosis: J Cutan Pathol 1992, 19:6-20
47. Regezi JA, MacPhail LA, Daniels TE, DeSouza YG, Greenspan JS, Greenspan D: Human immunodeficiency virus-associated oral Kaposi's sarcoma Am J Pathol 1993, 143:240-249